Acrylonitrile (2-propenenitrile; CAS 107-13-1; molecular weight 53.06; boiling point 77.3 °C) is an unsaturated nitrile monomer produced by vapor-phase ammoxidation of propylene over bismuth molybdate catalysts. The product is consumed mainly in polyacrylonitrile fiber, acrylonitrile-butadiene-styrene resin, styrene-acrylonitrile copolymer, and nitrile elastomer manufacturing. Acrylonitrile is transported under UN 1093, Class 3, Packing Group I; its flash point is approximately -5 °C and its flammable limits are about 3 vol% to 17 vol% in air. Toxicological assessment of the product is driven by three overlapping regulatory frameworks: the IARC classification, the California Proposition 65 cancer listing, and quantitative occupational exposure limits. The following technical review addresses the IARC class, the Proposition 65 no significant risk level, and the agency-specific 8-hour and short-term exposure limits that govern monomer storage, transfer, and polymerization operations.

IARC Monograph, Rodent Tumor Profiles, and Metabolic Activation

The IARC evaluation of acrylonitrile rests on sufficient evidence in experimental animals and inadequate evidence in humans. IARC Monographs Volume 71 (1999) classifies acrylonitrile as Group 2B, possibly carcinogenic to humans. Oral gavage studies in Fischer 344 rats produced statistically elevated incidences of brain astrocytomas, Zymbal gland carcinomas, and forestomach papillomas and carcinomas. Inhalation exposure in rats produced central nervous system tumors, although the exposure levels were high and nasal irritation was prominent. Mouse bioassays produced increases in liver and lung tumors, but species-specific differences in epoxide hydrolase and glutathione conjugation rates complicate direct dose extrapolation.

Metabolic activation occurs primarily through cytochrome P450 isoform CYP2E1, which oxidizes the terminal double bond to 2-cyanoethylene oxide. The epoxide is electrophilic and reacts with DNA to form N7-(2-cyano-2-hydroxyethyl)guanine and related cyano-hydroxyethyl adducts. Detoxification proceeds through glutathione conjugation to S-(2-cyanoethyl)glutathione, which is further processed to the urinary mercapturate N-acetyl-S-(2-cyanoethyl)-L-cysteine. The ratio of epoxide formation to glutathione conjugation is a critical determinant of tissue-specific tumor response in rodents. Published human biomonitoring data indicate that mercapturic acid excretion accounts for a reduced fraction of absorbed dose at higher exposure levels, suggesting saturable detoxification and a need for biomonitoring rather than air monitoring alone.

Genotoxicity data across bacterial and mammalian systems are consistently positive for acrylonitrile after metabolic activation. The compound induces gene mutations in Salmonella typhimurium strains TA1535 and TA100 only in the presence of S9 metabolic activation; in Chinese hamster ovary cells it induces sister chromatid exchanges and chromosomal aberrations. These endpoints support a clastogenic and mutagenic mode of action in vitro, but the in vivo relevance at occupational exposure concentrations is uncertain. The IARC mechanistic review did not classify the compound solely on genotoxicity; the animal tumor evidence was judged sufficient.

Epidemiological cohorts in acrylic fiber and resin production have not yielded consistent exposure-response relationships for lung cancer or brain cancer. The IARC Working Group considered the human evidence inadequate because exposures were frequently mixed with other monomers, and follow-up across studies did not reproduce a single tumor profile. The Group 2B classification therefore reflects the strength of the rodent bioassays, the positive genotoxicity data, and the metabolic activation pathway rather than a confirmed human cancer site. Under EU CLP Regulation (EC) 1272/2008, Annex VI, acrylonitrile is assigned a harmonized Carcinogen Category 1B classification with Hazard Statement H350, which is a separate regulatory instrument from the IARC monograph.

Acrylonitrile is listed under California Proposition 65 as a chemical known to the State to cause cancer. The listing is independent of the IARC Group 2B classification and carries separate warning and exposure assessment obligations for products sold in California. The Office of Environmental Health Hazard Assessment established a no significant risk level of 0.1 µg/day for the carcinogenic effect under Title 27, California Code of Regulations, section 25705. The NSRL is not an occupational exposure limit; it is a daily intake level below which a Proposition 65 warning is not required. For a volatile liquid with recognized dermal uptake, total dose for Proposition 65 exposure assessment includes inhalation, oral ingestion from hand-to-mouth contact, and dermal absorption from liquid or vapor contact. Analytical confirmation at the NSRL level in food-contact materials and consumer goods typically requires headspace GC-MS or purge-and-trap GC-MS with detection limits below 0.01 µg/L in aqueous simulants. Manufacturers of ABS or SAN resins with residual acrylonitrile below the relevant migration threshold may still need a warning if the article releases more than 0.1 µg/day under reasonably anticipated use.

What Numerical Limits Govern Occupational Exposure to Acrylonitrile?

The quantitative occupational exposure framework for acrylonitrile differs across agencies because each standard applies different risk assumptions and short-term excursion criteria. Table 2 summarizes enforceable and recommended limits.

Under 29 CFR 1910.1045(c)(1), the OSHA permissible exposure limit is 2 ppm (4.5 mg/m3) as an 8-hour time-weighted average, with a 15-minute ceiling of 10 ppm (22.5 mg/m3). The action level is 1 ppm (2.2 mg/m3) as an 8-hour TWA. Employers must conduct initial monitoring under 29 CFR 1910.1045(e)(1); if exposure exceeds the action level, periodic monitoring is required at least every 6 months, and if exposure exceeds the PEL, monitoring must be repeated at least every 3 months. Medical surveillance provisions apply to employees exposed above the action level for more than 30 days per year. These requirements are enforceable under the Occupational Safety and Health Act and are separate from the California warning obligation.

The NIOSH recommended exposure limit is 1 ppm (2.2 mg/m3) as a 10-hour TWA, with a 15-minute ceiling of 10 ppm (22.5 mg/m3) and a skin notation. ACGIH assigns a Threshold Limit Value of 2 ppm (4.3 mg/m3) as an 8-hour TWA with skin notation and A3 classification. The European Union binding occupational exposure limit under Directive 2019/983/EU is 1 ppm (2.2 mg/m3) as an 8-hour TWA, with a short-term exposure limit of 4 ppm (8.8 mg/m3) and skin notation. The differences between the OSHA PEL and the NIOSH or EU limit are not attributable to a single toxicological threshold but to the respective regulatory processes and the weight given to carcinogenic potential versus acute effects.

Air sampling for acrylonitrile uses solid sorbent tubes. NIOSH Method 1604 specifies coconut charcoal tubes, desorption with 2% acetone in carbon disulfide, and analysis by gas chromatography with flame ionization detection. OSHA Method 37 also uses charcoal tube sampling and GC-FID. Diffusive samplers may be used only after validation against the active method under the specific humidity and co-solvent conditions of the workplace. Sampling during reactor cleaning, filter changes, and drum transfer requires short-duration ceiling samples in addition to full-shift TWA samples.

Engineering controls required under 29 CFR 1910.1045(g) include enclosure of transfer and reaction vessels, local exhaust ventilation at points of monomer discharge, and routine inspection of mechanical seals. Work practices such as draining sample lines into closed containers and flushing pump seals with nitrogen reduce peak emission. Respiratory protection under 29 CFR 1910.134 is used only as an interim measure or for breakthrough maintenance; air-purifying respirators with organic vapor cartridges have limited service life because acrylonitrile is weakly adsorbed on activated carbon. Supplied-air respirators are recommended for reactor entry and for operations where concentrations may exceed the 10 ppm ceiling.

When Air Sampling Fails to Capture Dermal Uptake, Biological Monitoring Becomes Necessary

Air concentration alone underestimates total acrylonitrile uptake. Acrylonitrile is a low-molecular-weight unsaturated nitrile with high dermal permeability; the skin notation in the OSHA, NIOSH, ACGIH, and EU standards indicates that dermal absorption can contribute a biologically meaningful internal dose even when the 8-hour inhalation TWA is below 1 ppm. In liquid handling operations, glove contact with acrylonitrile-saturated clothing can extend exposure duration because the chemical is not volatilized from the fabric immediately. Chemical protective gloves should be selected using permeation data under ASTM F739; acrylonitrile permeates many elastomeric glove materials, and manufacturer-reported breakthrough times should be treated as maximum-use limits. Eye protection and face shields are required for splash handling because the monomer is intensely irritating and rapidly absorbed through mucous membranes. Where splash potential exists, emergency eyewash and shower units conforming to ANSI Z358.1 are required because dermal exposure can produce severe dermatitis and systemic toxicity.

Biological monitoring of the urinary metabolite N-acetyl-S-(2-cyanoethyl)-L-cysteine provides an integrative measure of inhalation plus dermal exposure. Published methods for this metabolite use LC-MS/MS after acid hydrolysis of the mercapturate; the analysis is sensitive to low microgram-per-liter urine levels. However, the OSHA standard does not require biological monitoring, and the metabolite is not a compliance metric under 29 CFR 1910.1045. Meeting the OSHA PEL does not automatically satisfy Proposition 65 or the NIOSH recommended exposure limit, because the OSHA PEL is higher than both the NIOSH REL and the EU binding limit.

In polymer-grade acrylonitrile storage and transfer, exposure risk concentrates at mechanical seals, sample points, filter housings, and reactor openings. The monomer is typically stabilized with monomethyl ether of hydroquinone at 35–50 mg/kg to prevent runaway polymerization during transport and storage. The inhibitor is depleted by prolonged heating above 40 °C, by oxygen exclusion, or by contact with strong alkali; exothermic self-polymerization generates heat and can increase airborne monomer concentration. Closed-loop transfer systems with nitrogen padding and pressure/vacuum relief valves are used to minimize fugitive emissions. Reactor unloading and slurry transfer in polyacrylonitrile production should be enclosed and purged to reduce short-term peak exposure. Published data for manual drum handling in small compounding operations is limited; therefore initial exposure monitoring under 29 CFR 1910.1045(e)(1) remains the only reliable basis for determining whether engineering controls are adequate.

Residual acrylonitrile in finished polymers is controlled by specification. For food-contact acrylonitrile copolymers, 21 CFR 177.1020 sets migration limits and residual monomer restrictions. Producers reduce residual acrylonitrile by vacuum stripping, monomer recovery, and extended devolatilization at elevated temperature. Residual acrylonitrile in high-nitrogen polyacrylonitrile fibers can be lowered to below 1 mg/kg by optimized washing and drawing, but published data for specific resin lines is limited. Testing of residual acrylonitrile in resin pellets uses headspace GC-FID or dissolution followed by liquid injection; method detection limits should be below 0.5 mg/kg for trade compliance.